Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN
Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF signifi...
Saved in:
Published in | International journal of molecular sciences Vol. 18; no. 9; p. 1957 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
12.09.2017
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF significantly inhibited the infection of the four serotypes of DENV in Vero cells. In the time-of-drug addition test, DENV-2 infection was remarkably inhibited when bLF was added during or prior to the occurrence of virus attachment. We also revealed that bovine LF blocks binding between DENV-2 and the cellular membrane by interacting with heparan sulfate (HS), dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), and low-density lipoprotein receptors (LDLR). In addition, bLF inhibits DENV-2 infection and decreases morbidity in a suckling mouse challenge model. This study supports the finding that bLF may inhibit DENV infection by binding to the potential DENV receptors. |
---|---|
AbstractList | Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF significantly inhibited the infection of the four serotypes of DENV in Vero cells. In the time-of-drug addition test, DENV-2 infection was remarkably inhibited when bLF was added during or prior to the occurrence of virus attachment. We also revealed that bovine LF blocks binding between DENV-2 and the cellular membrane by interacting with heparan sulfate (HS), dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), and low-density lipoprotein receptors (LDLR). In addition, bLF inhibits DENV-2 infection and decreases morbidity in a suckling mouse challenge model. This study supports the finding that bLF may inhibit DENV infection by binding to the potential DENV receptors.Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF significantly inhibited the infection of the four serotypes of DENV in Vero cells. In the time-of-drug addition test, DENV-2 infection was remarkably inhibited when bLF was added during or prior to the occurrence of virus attachment. We also revealed that bovine LF blocks binding between DENV-2 and the cellular membrane by interacting with heparan sulfate (HS), dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), and low-density lipoprotein receptors (LDLR). In addition, bLF inhibits DENV-2 infection and decreases morbidity in a suckling mouse challenge model. This study supports the finding that bLF may inhibit DENV infection by binding to the potential DENV receptors. Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue virus (DENV) infection. In this study, we evaluated the antiviral effect of bLF against DENV infection in vivo and in vitro. Bovine LF significantly inhibited the infection of the four serotypes of DENV in Vero cells. In the time-of-drug addition test, DENV-2 infection was remarkably inhibited when bLF was added during or prior to the occurrence of virus attachment. We also revealed that bovine LF blocks binding between DENV-2 and the cellular membrane by interacting with heparan sulfate (HS), dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), and low-density lipoprotein receptors (LDLR). In addition, bLF inhibits DENV-2 infection and decreases morbidity in a suckling mouse challenge model. This study supports the finding that bLF may inhibit DENV infection by binding to the potential DENV receptors. |
Author | Chen, Jo-Mei Lin, Jen-Wei Chiou, Shyan-Song Hsu, Wei-Li Fan, Yi-Chin Chen, Yi-Ying |
AuthorAffiliation | Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan; chenjm0317@gmail.com (J.-M.C.); yichinfan0309@gmail.com (Y.-C.F.); provista.wei@gmail.com (J.-W.L.); irisgf1986@gmail.com (Y.-Y.C.); wlhsu@dragon.nchu.edu.tw (W.-L.H.) |
AuthorAffiliation_xml | – name: Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan; chenjm0317@gmail.com (J.-M.C.); yichinfan0309@gmail.com (Y.-C.F.); provista.wei@gmail.com (J.-W.L.); irisgf1986@gmail.com (Y.-Y.C.); wlhsu@dragon.nchu.edu.tw (W.-L.H.) |
Author_xml | – sequence: 1 givenname: Jo-Mei surname: Chen fullname: Chen, Jo-Mei – sequence: 2 givenname: Yi-Chin surname: Fan fullname: Fan, Yi-Chin – sequence: 3 givenname: Jen-Wei surname: Lin fullname: Lin, Jen-Wei – sequence: 4 givenname: Yi-Ying surname: Chen fullname: Chen, Yi-Ying – sequence: 5 givenname: Wei-Li orcidid: 0000-0002-1392-163X surname: Hsu fullname: Hsu, Wei-Li – sequence: 6 givenname: Shyan-Song surname: Chiou fullname: Chiou, Shyan-Song |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28895925$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk-PEyEYhydmjftHb54NiRcPHQWmMHAx0a7uNplo4qpXwjDvtDRTGIHppp_Ary3N7pq68QS8PL8nL-E9L06cd1AULwl-W1USv7ObbSQCSyJZ_aQ4I3NKS4x5fXK0Py3OY9xgTCvK5LPilAohmaTsrPj90e-sA9Rok3wPIViHlm5tW5siugS3mgD9tGGKudqDSXZn0x61-3xMEHLIuhW6tWmNrmHUQTt0Mw29TjBDjb8tsyEeAo0d_Rh8gqz_BgbG5MMMadehy0V5s7z68rx42ushwov79aL48fnT98V12Xy9Wi4-NKWZE5pKplsgkra1ILhumWBdzzrS94wxUwkDWDAuKe9bLroOak5ZLaWhrOpJPefSVBfF-zvvOLVb6Ay4FPSgxmC3OuyV11b9e-PsWq38TjFOBMc8C97cC4L_NUFMamujgWHQDvwUFZGVIKIWc5HR14_QjZ-Cy8_LFKOUCMFZpl4dd_S3lYc_ygC9A0zwMQbolbFJJ-sPDdpBEawOg6COByGHZo9CD97_4n8AmQy15w |
CitedBy_id | crossref_primary_10_1080_20013078_2020_1808281 crossref_primary_10_2147_IDR_S376401 crossref_primary_10_1080_19390211_2020_1834047 crossref_primary_10_3389_fimmu_2024_1402135 crossref_primary_10_3390_biomedicines9121896 crossref_primary_10_1051_medsci_2025025 crossref_primary_10_1080_10408398_2021_1895063 crossref_primary_10_3390_ijms22115799 crossref_primary_10_3390_v15030705 crossref_primary_10_15789_2220_7619_POL_1156 crossref_primary_10_3390_ijms25031842 crossref_primary_10_3390_v13071312 crossref_primary_10_3389_fcimb_2018_00388 crossref_primary_10_1016_j_cellin_2024_100196 crossref_primary_10_1016_j_jacl_2021_09_048 crossref_primary_10_1016_j_heliyon_2021_e08087 crossref_primary_10_1042_BST20170398 crossref_primary_10_1007_s00253_021_11267_1 crossref_primary_10_33380_2305_2066_2022_11_1_32_39 crossref_primary_10_3390_ph16101352 crossref_primary_10_1002_fsn3_3314 crossref_primary_10_1007_s00018_019_03138_w crossref_primary_10_1007_s10238_022_00851_y crossref_primary_10_1016_j_jbc_2024_107849 crossref_primary_10_3390_v11080704 crossref_primary_10_1016_j_lfs_2024_123340 crossref_primary_10_1007_s12011_023_03658_4 crossref_primary_10_1016_j_abb_2024_110171 crossref_primary_10_1186_s12985_024_02608_3 crossref_primary_10_3390_nu13030870 crossref_primary_10_1080_17460441_2022_2033205 crossref_primary_10_1007_s12602_024_10430_0 crossref_primary_10_3390_ph17081021 crossref_primary_10_3389_fimmu_2020_01221 crossref_primary_10_3390_nano14242018 crossref_primary_10_1016_j_sajb_2024_04_045 crossref_primary_10_1007_s10719_021_10029_5 crossref_primary_10_1042_BSR20240134 crossref_primary_10_1007_s10989_020_10072_0 crossref_primary_10_1016_j_micres_2022_127206 crossref_primary_10_3390_pharmaceutics14091862 crossref_primary_10_1038_s41467_024_48989_5 crossref_primary_10_22159_ijcpr_2022v14i3_1984 crossref_primary_10_3390_pharmaceutics15041056 crossref_primary_10_1038_s41467_024_44872_5 crossref_primary_10_3390_v16111692 crossref_primary_10_1002_ame2_12145 |
Cites_doi | 10.1016/j.bbrc.2005.05.171 10.1016/j.antiviral.2005.03.005 10.1101/071571 10.1016/j.virol.2005.01.010 10.3390/v7020480 10.1016/S1386-6346(02)00088-8 10.1146/annurev.nu.15.070195.000521 10.1038/nm0897-866 10.1371/journal.pone.0021658 10.1016/j.antiviral.2005.10.006 10.1016/S1095-6433(99)00122-1 10.1111/imb.12334 10.1128/JVI.78.22.12647-12656.2004 10.1016/j.virol.2013.04.003 10.1016/S0304-4165(01)00222-7 10.1016/j.antiviral.2014.08.012 10.1159/000080882 10.1186/s12917-016-0878-2 10.1007/s004300050093 10.1128/CMR.3.4.376 10.1073/pnas.96.22.12766 10.1016/S0166-3542(01)00195-4 10.1084/jem.20021840 10.1124/jpet.116.239574 10.1128/JVI.79.5.3009-3015.2005 10.1006/viro.1999.9633 10.1371/journal.pntd.0001636 10.1046/j.1432-1033.2003.03715.x 10.1016/j.virol.2008.06.017 10.1016/j.virol.2009.01.043 10.1093/clinids/11.Supplement_4.S830 10.1074/jbc.M504337200 10.1053/jhep.2000.18713 10.1007/978-1-4757-9068-9_13 10.1016/j.antiviral.2011.07.002 10.1006/abbi.1995.1139 10.1111/j.1747-0285.2008.00715.x |
ContentType | Journal Article |
Copyright | Copyright MDPI AG 2017 2017 by the authors. 2017 |
Copyright_xml | – notice: Copyright MDPI AG 2017 – notice: 2017 by the authors. 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 5PM |
DOI | 10.3390/ijms18091957 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central Database Suite (ProQuest) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | PMC5618606 28895925 10_3390_ijms18091957 |
Genre | Journal Article |
GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR IPNFZ ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RIG RNS RPM TR2 TUS UKHRP ~8M 3V. ABJCF BBNVY BHPHI CGR CUY CVF ECM EIF GROUPED_DOAJ HCIFZ KB. M7P M~E NPM PDBOC 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c412t-5abe192b78107b585df5d1ff555c38ce0856926fb68dde7625799c253f17469c3 |
IEDL.DBID | M48 |
ISSN | 1422-0067 1661-6596 |
IngestDate | Thu Aug 21 17:56:06 EDT 2025 Mon Jul 21 11:05:21 EDT 2025 Fri Jul 25 20:17:51 EDT 2025 Wed Feb 19 02:42:39 EST 2025 Tue Jul 01 03:30:04 EDT 2025 Thu Apr 24 23:05:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | heparan sulfate low-density lipoprotein receptor DC-SIGN bovine lactoferrin dengue virus |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c412t-5abe192b78107b585df5d1ff555c38ce0856926fb68dde7625799c253f17469c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-1392-163X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms18091957 |
PMID | 28895925 |
PQID | 1952218865 |
PQPubID | 2032341 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5618606 proquest_miscellaneous_1938187848 proquest_journals_1952218865 pubmed_primary_28895925 crossref_citationtrail_10_3390_ijms18091957 crossref_primary_10_3390_ijms18091957 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-09-12 |
PublicationDateYYYYMMDD | 2017-09-12 |
PublicationDate_xml | – month: 09 year: 2017 text: 2017-09-12 day: 12 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationTitleAlternate | Int J Mol Sci |
PublicationYear | 2017 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Lonnerdal (ref_2) 1995; 15 Chen (ref_11) 1997; 3 Berges (ref_19) 2005; 333 Lozach (ref_13) 2005; 280 Henchal (ref_9) 1990; 3 Bouchard (ref_37) 2014; 111 Beleid (ref_4) 2008; 72 Harada (ref_36) 1999; 124 ref_31 Marchetti (ref_21) 1999; 187 Chien (ref_6) 2008; 379 ref_17 Schuller (ref_35) 2011; 92 Weng (ref_3) 2005; 67 ref_15 Legrand (ref_5) 2001; 1568 Pietrantoni (ref_22) 2006; 69 Hara (ref_23) 2002; 24 Kerr (ref_32) 2017; 361 Thepparit (ref_34) 2004; 78 Tassaneetrithep (ref_12) 2003; 197 ref_20 Beljaars (ref_1) 2001; 52 Jindadamrongwech (ref_33) 2004; 47 Hilgard (ref_27) 2000; 32 Pietrantoni (ref_24) 2015; 7 Alen (ref_14) 2009; 387 Agnello (ref_29) 1999; 96 Halstead (ref_8) 1989; 11 ref_26 Wu (ref_28) 1995; 317 Hung (ref_10) 1999; 257 Waarts (ref_16) 2005; 333 Huettinger (ref_18) 1998; 443 Groot (ref_7) 2005; 79 Kanyshkova (ref_25) 2003; 270 Mosso (ref_30) 2013; 442 12393024 - Hepatol Res. 2002 Nov;24(3):228 15564750 - Intervirology. 2004;47(6):370-3 11050058 - Hepatology. 2000 Nov;32(5):1069-77 2665015 - Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9 11675140 - Antiviral Res. 2001 Dec;52(3):225-39 15916817 - Antiviral Res. 2005 Jul;67(1):31-7 16386316 - Antiviral Res. 2006 Feb;69(2):98-106 15507651 - J Virol. 2004 Nov;78(22):12647-56 10535997 - Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12766-71 23642566 - Virology. 2013 Aug 1;442(2):132-47 21738755 - PLoS One. 2011;6(6):e21658 10665381 - Comp Biochem Physiol A Mol Integr Physiol. 1999 Nov;124(3):321-7 25193851 - Antiviral Res. 2014 Nov;111:13-22 19264337 - Virology. 2009 Apr 25;387(1):67-75 25643293 - Viruses. 2015 Jan 29;7(2):480-95 11786226 - Biochim Biophys Acta. 2001 Dec 19;1568(3):197-204 10208929 - Virology. 1999 Apr 25;257(1):156-67 18640695 - Virology. 2008 Sep 15;379(1):143-51 10363676 - Med Microbiol Immunol. 1999 May;187(4):199-204 28718976 - Insect Mol Biol. 2017 Jul 18;:null 27829421 - BMC Vet Res. 2016 Nov 10;12 (1):251 12899692 - Eur J Biochem. 2003 Aug;270(16):3353-61 9256277 - Nat Med. 1997 Aug;3(8):866-71 7872808 - Arch Biochem Biophys. 1995 Feb 20;317(1):85-92 15709021 - J Virol. 2005 Mar;79(5):3009-15 21763725 - Antiviral Res. 2011 Oct;92(1):96-101 15721362 - Virology. 2005 Mar 15;333(2):284-92 15963458 - Biochem Biophys Res Commun. 2005 Aug 5;333(3):896-907 28699858 - J Gen Virol. 2017 Jul;98 (7):1749-1754 28360334 - J Pharmacol Exp Ther. 2017 Jun;361(3):417-428 2224837 - Clin Microbiol Rev. 1990 Oct;3(4):376-96 12682107 - J Exp Med. 2003 Apr 7;197(7):823-9 22563515 - PLoS Negl Trop Dis. 2012;6(5):e1636 9781349 - Adv Exp Med Biol. 1998;443:107-11 19012577 - Chem Biol Drug Des. 2008 Nov;72(5):436-43 15855154 - J Biol Chem. 2005 Jun 24;280(25):23698-708 8527233 - Annu Rev Nutr. 1995;15:93-110 |
References_xml | – volume: 333 start-page: 896 year: 2005 ident: ref_19 article-title: A cell line model for the differentiation of human dendritic cells publication-title: Biochemic. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2005.05.171 – volume: 67 start-page: 31 year: 2005 ident: ref_3 article-title: Lactoferrin inhibits enterovirus 71 infection by binding to vp1 protein and host cells publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2005.03.005 – ident: ref_17 doi: 10.1101/071571 – volume: 333 start-page: 284 year: 2005 ident: ref_16 article-title: Antiviral activity of human lactoferrin: Inhibition of alphavirus interaction with heparan sulfate publication-title: Virology doi: 10.1016/j.virol.2005.01.010 – volume: 7 start-page: 480 year: 2015 ident: ref_24 article-title: Bovine lactoferrin inhibits toscana virus infection by binding to heparan sulphate publication-title: Viruses doi: 10.3390/v7020480 – volume: 24 start-page: 228 year: 2002 ident: ref_23 article-title: Lactoferrin inhibits hepatitis b virus infection in cultured human hepatocytes publication-title: Hepatol. Res. doi: 10.1016/S1386-6346(02)00088-8 – volume: 15 start-page: 93 year: 1995 ident: ref_2 article-title: Lactoferrin: Molecular structure and biological function publication-title: Annu. Rev. Nutr. doi: 10.1146/annurev.nu.15.070195.000521 – volume: 3 start-page: 866 year: 1997 ident: ref_11 article-title: Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate publication-title: Nat. Med. doi: 10.1038/nm0897-866 – ident: ref_15 doi: 10.1371/journal.pone.0021658 – volume: 69 start-page: 98 year: 2006 ident: ref_22 article-title: Bovine lactoferrin peptidic fragments involved in inhibition of echovirus 6 in vitro infection publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2005.10.006 – volume: 124 start-page: 321 year: 1999 ident: ref_36 article-title: Characteristic transport of lactoferrin from the intestinal lumen into the bile via the blood in piglets publication-title: Comp. Biochem. Physiol. Mol. Integr. Physiol. doi: 10.1016/S1095-6433(99)00122-1 – ident: ref_31 doi: 10.1111/imb.12334 – volume: 78 start-page: 12647 year: 2004 ident: ref_34 article-title: Serotype-specific entry of dengue virus into liver cells: Identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor publication-title: J. Virol. doi: 10.1128/JVI.78.22.12647-12656.2004 – volume: 442 start-page: 132 year: 2013 ident: ref_30 article-title: The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in ldl particle uptake and hmg-coa reductase activity publication-title: Virology doi: 10.1016/j.virol.2013.04.003 – volume: 1568 start-page: 197 year: 2001 ident: ref_5 article-title: The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29–18-C1 cells is mediated through basic residues located in the N-terminus publication-title: Biochim. Biophys. Acta doi: 10.1016/S0304-4165(01)00222-7 – volume: 111 start-page: 13 year: 2014 ident: ref_37 article-title: The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune lactoferrin protein publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2014.08.012 – volume: 47 start-page: 370 year: 2004 ident: ref_33 article-title: Virus overlay protein binding assay (vopba) reveals serotype specific heterogeneity of dengue virus binding proteins on hepg2 human liver cells publication-title: Intervirology doi: 10.1159/000080882 – ident: ref_26 doi: 10.1186/s12917-016-0878-2 – volume: 187 start-page: 199 year: 1999 ident: ref_21 article-title: Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin publication-title: Med. Microbiol. Immunol. doi: 10.1007/s004300050093 – volume: 3 start-page: 376 year: 1990 ident: ref_9 article-title: The dengue viruses publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.3.4.376 – volume: 96 start-page: 12766 year: 1999 ident: ref_29 article-title: Hepatitis c virus and other flaviviridae viruses enter cells via low density lipoprotein receptor publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.96.22.12766 – volume: 52 start-page: 225 year: 2001 ident: ref_1 article-title: Antiviral activities of lactoferrin publication-title: Antivir. Res. doi: 10.1016/S0166-3542(01)00195-4 – volume: 197 start-page: 823 year: 2003 ident: ref_12 article-title: DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells publication-title: J. Exp. Med. doi: 10.1084/jem.20021840 – volume: 361 start-page: 417 year: 2017 ident: ref_32 article-title: A genomic DNA reporter screen identifies squalene synthase inhibitors that act cooperatively with statins to upregulate the low-density lipoprotein receptor publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.116.239574 – volume: 79 start-page: 3009 year: 2005 ident: ref_7 article-title: Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the Dc-SIGN—gp120 interaction publication-title: J. Virol. doi: 10.1128/JVI.79.5.3009-3015.2005 – volume: 257 start-page: 156 year: 1999 ident: ref_10 article-title: Analysis of the steps involved in dengue virus entry into host cells publication-title: Virology doi: 10.1006/viro.1999.9633 – ident: ref_20 doi: 10.1371/journal.pntd.0001636 – volume: 270 start-page: 3353 year: 2003 ident: ref_25 article-title: Multiple enzymic activities of human milk lactoferrin publication-title: Eur. J. Biochem. doi: 10.1046/j.1432-1033.2003.03715.x – volume: 379 start-page: 143 year: 2008 ident: ref_6 article-title: Bovine lactoferrin inhibits japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein publication-title: Virology doi: 10.1016/j.virol.2008.06.017 – volume: 387 start-page: 67 year: 2009 ident: ref_14 article-title: Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection publication-title: Virology doi: 10.1016/j.virol.2009.01.043 – volume: 11 start-page: S830 year: 1989 ident: ref_8 article-title: Antibody, macrophages, dengue virus infection, shock, and hemorrhage: A pathogenetic cascade publication-title: Rev. Infect. Dis. doi: 10.1093/clinids/11.Supplement_4.S830 – volume: 280 start-page: 23698 year: 2005 ident: ref_13 article-title: Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals publication-title: J. Biol. Chem. doi: 10.1074/jbc.M504337200 – volume: 32 start-page: 1069 year: 2000 ident: ref_27 article-title: Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes publication-title: Hepatology doi: 10.1053/jhep.2000.18713 – volume: 443 start-page: 107 year: 1998 ident: ref_18 article-title: The LDL-receptor family. Lactoferrin and lipid metabolism publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4757-9068-9_13 – volume: 92 start-page: 96 year: 2011 ident: ref_35 article-title: Tripeptide inhibitors of dengue and west nile virus NS2B-NS3 protease publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2011.07.002 – volume: 317 start-page: 85 year: 1995 ident: ref_28 article-title: Characterization of the glycosaminoglycan-binding region of lactoferrin publication-title: Arch. Biochem. Biophys. doi: 10.1006/abbi.1995.1139 – volume: 72 start-page: 436 year: 2008 ident: ref_4 article-title: Helical peptides derived from lactoferrin bind hepatitis c virus envelope protein e2 publication-title: Chem. Biol. Drug Des. doi: 10.1111/j.1747-0285.2008.00715.x – reference: 15721362 - Virology. 2005 Mar 15;333(2):284-92 – reference: 23642566 - Virology. 2013 Aug 1;442(2):132-47 – reference: 19012577 - Chem Biol Drug Des. 2008 Nov;72(5):436-43 – reference: 28699858 - J Gen Virol. 2017 Jul;98 (7):1749-1754 – reference: 16386316 - Antiviral Res. 2006 Feb;69(2):98-106 – reference: 11675140 - Antiviral Res. 2001 Dec;52(3):225-39 – reference: 11786226 - Biochim Biophys Acta. 2001 Dec 19;1568(3):197-204 – reference: 12682107 - J Exp Med. 2003 Apr 7;197(7):823-9 – reference: 27829421 - BMC Vet Res. 2016 Nov 10;12 (1):251 – reference: 2224837 - Clin Microbiol Rev. 1990 Oct;3(4):376-96 – reference: 28718976 - Insect Mol Biol. 2017 Jul 18;:null – reference: 2665015 - Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9 – reference: 21738755 - PLoS One. 2011;6(6):e21658 – reference: 25193851 - Antiviral Res. 2014 Nov;111:13-22 – reference: 10208929 - Virology. 1999 Apr 25;257(1):156-67 – reference: 19264337 - Virology. 2009 Apr 25;387(1):67-75 – reference: 9781349 - Adv Exp Med Biol. 1998;443:107-11 – reference: 9256277 - Nat Med. 1997 Aug;3(8):866-71 – reference: 10665381 - Comp Biochem Physiol A Mol Integr Physiol. 1999 Nov;124(3):321-7 – reference: 10363676 - Med Microbiol Immunol. 1999 May;187(4):199-204 – reference: 15855154 - J Biol Chem. 2005 Jun 24;280(25):23698-708 – reference: 15709021 - J Virol. 2005 Mar;79(5):3009-15 – reference: 22563515 - PLoS Negl Trop Dis. 2012;6(5):e1636 – reference: 15916817 - Antiviral Res. 2005 Jul;67(1):31-7 – reference: 15963458 - Biochem Biophys Res Commun. 2005 Aug 5;333(3):896-907 – reference: 28360334 - J Pharmacol Exp Ther. 2017 Jun;361(3):417-428 – reference: 21763725 - Antiviral Res. 2011 Oct;92(1):96-101 – reference: 8527233 - Annu Rev Nutr. 1995;15:93-110 – reference: 15507651 - J Virol. 2004 Nov;78(22):12647-56 – reference: 18640695 - Virology. 2008 Sep 15;379(1):143-51 – reference: 10535997 - Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12766-71 – reference: 12393024 - Hepatol Res. 2002 Nov;24(3):228 – reference: 12899692 - Eur J Biochem. 2003 Aug;270(16):3353-61 – reference: 25643293 - Viruses. 2015 Jan 29;7(2):480-95 – reference: 11050058 - Hepatology. 2000 Nov;32(5):1069-77 – reference: 15564750 - Intervirology. 2004;47(6):370-3 – reference: 7872808 - Arch Biochem Biophys. 1995 Feb 20;317(1):85-92 |
SSID | ssj0023259 |
Score | 2.4295554 |
Snippet | Bovine lactoferrin (bLF) presents in milk and has been shown to inhibit several viral infections. Effective drugs are unavailable for the treatment of dengue... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1957 |
SubjectTerms | Animals Antiviral Agents - pharmacology Cattle Cell Adhesion Molecules - metabolism Cell Line Cercopithecus aethiops Dengue - drug therapy Dengue fever Dengue Virus - drug effects Female Heparan sulfate Heparitin Sulfate - metabolism Humans Infections Inhibitory Concentration 50 Lactoferrin - pharmacology Lectins, C-Type - metabolism Low density lipoprotein Mice Mice, Inbred BALB C Pregnancy Receptors, Cell Surface - metabolism Receptors, LDL - metabolism Receptors, Virus - drug effects THP-1 Cells Vero Cells Viral infections Viral Plaque Assay Virus Attachment - drug effects |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4t2FgowEJ2p1E8evE4IuZYuWXkrR3qLEjzaoOEuzEeov4G8zk2S3XRBcYzuJMvb4m_Hk-wh5VSDhSVJy5rgKLPOZZ8YFyfzYJt4WwYUu4fb5SE5Psk9zMR8Sbs1QVrnyiZ2jdrXFHPleYgApJFpL8Xbxg6FqFJ6uDhIaN8ktpC7Dki41vwq4eNqJpSWwBzEpjOwL3zmE-XvVt-8NUlfBKLW5Jf2FM_8sl7y2_xzcI3cH4Ejf9Za-T274-IDc7qUkLx-SX-8xNeDpDPVzAtItRnoYz6qyWjZ04uNp6-nX6qJt4GpXfoWaEbS8pF1KEP9uiKcUk7J06pEOPNLj9jwAEN2ls_onm2CdOwyYVYu6o3aA2wPi9AsI2XdpER2d7LPjw49Hj8jJwYcv-1M2iCwwmyXpkomi9IDySqUhECwheHBBuCQEIYTl2nqAZNKkMpRSgycE1ymUMTYVPEAsI43lj8lWrKPfJtTJsVaw4atClZnz3HBji1R4HrRLXJKNyJvVd87twECOQhjnOUQiaJX8ulVG5PW696Jn3vhHv52VyfJh_TX51WwZkZfrZlg5eBxSRF-32AfRitKZHpEnvYXXD0q1NsKkMFpt2H7dAVm5N1tiddaxcwtUIBjLp_9_rWfkTooAoROj2CFby4vWPwd4syxfdHP4N4OA_Bs priority: 102 providerName: ProQuest |
Title | Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28895925 https://www.proquest.com/docview/1952218865 https://www.proquest.com/docview/1938187848 https://pubmed.ncbi.nlm.nih.gov/PMC5618606 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1bb9MwFD7aRUi8IO7LGJWR4IkFmotj-wEhtq7rUFchRlHfolzsLahzSy-C_gL-NuckTdQx9pKH-BLJx_b5jn3yfQCvEyI88dLAzQNh3FCH2lW5iVzdzjydJSY35YHb-SDqDcPPIz7aglptdD2A8_-GdqQnNZyN3_3-ufqIC_4DRZwYsr8vflzPiYbKU1xswy76JEFL9Dxs7hMQNnBVpb3fakF0wFIqrkgte9M33QKc_-ZNbjii7kN4sEaQ7FNl8kewpe1juFdpSq6ewJ8jOiPQrE9COoZ4Fy07s1dFWizmrKPt5VKz78VsOce3ZR4WiUewdMXKs0H6zcFeMjqdZT1NvOCWXSzHBhHpIetPfrkdSnjHBv1iOik5HrB7hJ56irH7IUtszjrH7sXZ6eApDLsn34577lptwc1Cz1-4PEk1wr1USIwIU4wicsNzzxjOeRbITCM2i5QfmTSSuCXiHsqFUpnPA4NBTaSy4Bns2InVe8DyqC0Fen6RiDTMdaAClSU-14GRuZd7oQNv63GOszUVOSlijGMMSchA8aaBHHjT1J5WFBx31DuoTRbX8yjGAh9RjIy4A6-aYlxCdC-SWD1ZUh2CLUKG0oHnlYWbD9VTwwFxw_ZNBaLnvllii6uSppuTFEE72r-zzxdw3yeQUApSHMDOYrbULxHiLNIWbIuRwKfsnrZg9-hk8OVri5wOb5Xz-i8zdQEw |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4s2WAkaiJ2o1iWPHPiAEXcou3e6lLdpbmsR2G9Q6yz5U7S_g3_AbmUl2t10Q3HpN7LzGY38znnwfIW8zJDwJc84MTxyLbWyZNk4yGxShLTJnXJ1wO-jLznH8dSAGa-TX4l8YLKtczIn1RG2qAnPkO6EGpBAqJcWH4Q-GqlG4u7qQ0GiGxb6dXULINn7fbYN9t6Jo7_PRbofNVQVYEYfRhIkstwBr8kRB5JMDWjZOmNA5IUTBVWEBg0gdSZdLBa4Pc4VItC4iwR2Ad6kLDte9RW7DwhugRyWDqwCPR7U4WwhrHpNCy6bQnnMd7JTfL8ZIlQWvkawugX_h2j_LM6-td3sPyP05UKUfm5H1kKxZ_4jcaaQrZ4_Jz0-YirC0h3o9DukdPe36szIvJ2Patv50aum3cjQdw9G63As1Kmg-o3UKEv-m8KcUk8C0Y5F-3NPD6bkD4LtNe9Ula2NdPXTolcOqppKAywPCtcNJNdqmmTe0vcsOu1_6T8jxjXz-p2TdV94-J9TIQCUAMJIsyWNjuea6yCJhuVMmNGHcIu8W3zkt5oznKLxxnkLkg1ZJr1ulRbaWrYcN08c_2m0uTJbO_X2cXo3OFnmzPA2eitsvmbfVFNsgOkpUrFrkWWPh5Y0ipbTQEfROVmy_bIAs4KtnfHlWs4ELVDwI5Mb_H-s1uds5OuilvW5__wW5FyE4qYUwNsn6ZDS1LwFaTfJX9Xim5OSmHeg3uho39Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFLXGEIgXxDeFAUZiT8xqE8eO_YAQrJSWlQppDPUtJLG9BQ2ntI2m_gL-E7-Oe5O2W0HwttfEztf1tc-9vjmHkBcpEp4EGWeGx45FNrJMGyeZ7eSBzVNnXJ1w-ziS_aPow1iMt8iv1b8wWFa5mhPridqUOebI24EGpBAoJUXbLcsiPnV7ryc_GCpI4U7rSk6jGSIHdnEG4dvs1aALtt4Nw967z_t9tlQYYHkUhHMm0swCxMliBVFQBsjZOGEC54QQOVe5BTwidShdJhVMAzBviFjrPBTcAZCXOudw3SvkasxFgD4Wj8-DPR7WQm0BrH9MCi2bonvOdaddfPs-Q9oseKV4czn8C-P-Wap5Ye3r3SI3l6CVvmlG2W2yZf0dcq2RsVzcJT_fYlrC0iFq9zikevR04E-KrJjPaNf648rSL8W0msHRuvQL9SpotqB1OhL_rPDHFBPCtG-RitzTw-rUAQjeo8PyjHWxxh46DItJWdNKwOUB7drJvJzu0dQb2t1nh4P3o3vk6FI-_32y7UtvHxJqZEfFADbiNM4iY7nmOk9DYblTJjBB1CIvV985yZfs5yjCcZpAFIRWSS5apUV2160nDevHP9rtrEyWLH1_lpyP1BZ5vj4NXotbMam3ZYVtECnFKlIt8qCx8PpGoVJa6BB6xxu2XzdARvDNM744qZnBBaofdOSj_z_WM3IdXCcZDkYHj8mNEHFKXTS3Q7bn08o-AZQ1z57Ww5mSr5ftP78BGUY8KQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bovine+Lactoferrin+Inhibits+Dengue+Virus+Infectivity+by+Interacting+with+Heparan+Sulfate%2C+Low-Density+Lipoprotein+Receptor%2C+and+DC-SIGN&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Chen%2C+Jo-Mei&rft.au=Fan%2C+Yi-Chin&rft.au=Lin%2C+Jen-Wei&rft.au=Chen%2C+Yi-Ying&rft.date=2017-09-12&rft.eissn=1422-0067&rft.volume=18&rft.issue=9&rft_id=info:doi/10.3390%2Fijms18091957&rft_id=info%3Apmid%2F28895925&rft.externalDocID=28895925 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |